Damian Marron
Chairman of the Board of Directors
About us
ELYSEA Life Sciences Group is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health.
Board of directors
-
-
Gavin Spencer
Chief Executive Officer
-
Marc Le Bozec
Director
-
Christine Placet
Executive team
-
Gavin Spencer
Chief Executive Officer
-
Sandrine Gestin
Vice President, Finance and Human Resources
-
Emmet Purtill
Vice President, Business Development
Scientific team
-
Siobhan Garbutt
Vice President and Head of Clinical Development
-
Doug Hubatsch
Chief Scientific Advisor
Principal partnerships
| Partner | Program | Territory |
|---|---|---|
| Kowa Nagoya, Japan · est. 1894 | NCX 470 | Japan, U.S. and all other territories outside China, Korea and Southeast Asia |
| Ocumension Therapeutics China · listed on the Hong Kong Exchange | NCX 470 | China, Korea and Southeast Asia |
| ZERVIATE® | China and the majority of Southeast Asian markets | |
| Bausch + Lomb | VYZULTA® | Worldwide |
| Harrow | ZERVIATE® | U.S. |
| Glaukos | NCX 1728 | Research and global licensing option agreement |
Contact
France
Nicox SA
Sundesk Sophia Antipolis, Bâtiment C, Emerald Square, rue Evariste Galois, 06410 Biot, France
+33 (0)4 97 24 53 00USA
Nicox Ophthalmics, Inc.
4819 Emperor Blvd., Suite 400, Durham, NC 27703, USA
+1 984 710 5354